---
figid: PMC5400658__oncotarget-08-22203-g002
figtitle: Dysregulations in the PI3K pathway and targeted therapies for head and neck
  squamous cell carcinoma
organisms:
- NA
pmcid: PMC5400658
filename: oncotarget-08-22203-g002.jpg
figlink: /pmc/articles/PMC5400658/figure/F2/
number: F2
caption: . The PI3K signaling pathway's key players and inhibitors under investigation
  in HNSCC trials.
papertitle: Dysregulations in the PI3K pathway and targeted therapies for head and
  neck squamous cell carcinoma.
reftext: Yi Cai, et al. Oncotarget. 2017 Mar 28;8(13):22203-22217.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9633384
figid_alias: PMC5400658__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC5400658__F2
ndex: ebd8d30e-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5400658__oncotarget-08-22203-g002.html
  '@type': Dataset
  description: . The PI3K signaling pathway's key players and inhibitors under investigation
    in HNSCC trials.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - Tie
  - Ras85D
  - InR
  - pk
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - pan
  - Panx
  - Myb
  - Taf5
  - Pten
  - Akt
  - Pdk
  - Pdk1
  - Mtor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Temsirolimus
  - Ridaforolimus
  - SF1126
  - BYL-719
  - NVP-BYL719
  - Metformin
  - Sirolimus
---
